Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2007-08-29 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BEAUMONT-LES-VALENCE (26760), Drome
PHARMACIE DES PINS : revenue, balance sheet and financial ratios
PHARMACIE DES PINS is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BEAUMONT-LES-VALENCE (26760),
this company of category PME
shows in 2025 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES PINS (SIREN 499700839)
Indicator
2025
2024
2022
2021
2020
2019
2018
2017
2016
Revenue
2 197 403 €
2 291 543 €
2 128 927 €
1 987 112 €
1 938 945 €
1 844 751 €
1 844 914 €
1 825 023 €
1 862 495 €
Net income
67 443 €
54 994 €
148 861 €
144 191 €
99 130 €
129 979 €
131 680 €
131 846 €
137 485 €
EBITDA
84 062 €
74 165 €
175 643 €
176 714 €
125 882 €
151 761 €
163 630 €
169 461 €
179 890 €
Net margin
3.1%
2.4%
7.0%
7.3%
5.1%
7.0%
7.1%
7.2%
7.4%
Revenue and income statement
In 2025, PHARMACIE DES PINS achieves revenue of 2.2 M€. Revenue is growing positively over 9 years (CAGR: +1.9%). Slight decline of -4% vs 2024. After deducting consumption (1.5 M€), gross margin stands at 672 k€, i.e. a rate of 31%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 84 k€, representing 3.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 67 k€, i.e. 3.1% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2025)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
2 197 403 €
Gross margin (2025)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
672 221 €
EBITDA (2025)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
84 062 €
EBIT (2025)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
91 560 €
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
67 443 €
EBITDA margin (2025)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
3.8%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 88%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.283%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
88.4%
Cash flow / Revenue (2025)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
3.857%
Repayment capacity (2025)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.262
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Debt ratio
39.731
32.941
18.254
5.559
4.074
21.996
5.197
1.776
1.283
Financial autonomy
64.267
67.958
76.427
84.264
85.901
74.546
86.005
87.903
88.4
Repayment capacity
3.086
2.877
1.703
0.551
0.55
2.265
0.55
0.43
0.262
Cash flow / Revenue
7.428%
7.417%
7.49%
7.646%
5.616%
7.778%
7.598%
3.105%
3.857%
Sector positioning
Debt ratio
1.282025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE DES PINS (1.28) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
88.4%2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES PINS (88.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.26 years2025
2022
2024
2025
Q1: 0.51 years
Med: 2.46 years
Q3: 6.17 years
Excellent
In 2025, the repayment capacity of PHARMACIE DES PINS (0.26) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 283.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.4x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
283.252
Interest coverage (2025)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.383
Liquidity indicators evolution PHARMACIE DES PINS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Liquidity ratio
184.548
165.915
144.229
119.139
156.202
373.106
310.373
274.969
283.252
Interest coverage
8.737
6.931
4.704
1.958
0.407
0.22
0.239
0.386
0.383
Sector positioning
Liquidity ratio
283.252025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE DES PINS (283.25) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.38x2025
2022
2024
2025
Q1: 0.0x
Med: 1.91x
Q3: 5.98x
Average
In 2025, the interest coverage of PHARMACIE DES PINS (0.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 3 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 35 days. Excellent situation: suppliers finance 32 days of the operating cycle (retail model). Inventory turnover is 36 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 33 days of revenue, i.e. 204 k€ to permanently finance. Over 2016-2025, WCR increased by +25%, requiring additional financing.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
203 699 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
3 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
35 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
36 j
WCR in days of revenue (2025)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
33 j
WCR and payment terms evolution PHARMACIE DES PINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Operating WCR
163 453 €
164 015 €
168 256 €
171 875 €
193 604 €
186 987 €
185 728 €
205 185 €
203 699 €
Inventory turnover (days)
29
30
31
32
33
35
32
34
36
Customer payment term (days)
4
2
2
2
3
4
2
1
3
Supplier payment term (days)
34
34
33
39
37
36
36
32
35
Positioning of PHARMACIE DES PINS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES PINS is estimated at
938 796 €
(range 603 756€ - 1 270 024€).
With an EBITDA of 84 062€, the sector multiple of 7.7x is applied.
The price/revenue ratio is 0.61x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
603k€938k€1270k€
938 796 €Range: 603 756€ - 1 270 024€
NAF 5 année 2025
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
84 062 €×7.7x
Estimation648 984 €
327 280€ - 944 786€
Revenue Multiple30%
2 197 403 €×0.61x
Estimation1 333 454 €
982 378€ - 1 538 053€
Net Income Multiple20%
67 443 €×15.9x
Estimation1 071 340 €
727 016€ - 1 681 080€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES PINS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES PINS
What is the revenue of PHARMACIE DES PINS ?
The revenue of PHARMACIE DES PINS in 2025 is 2.2 M€.
Is PHARMACIE DES PINS profitable?
Yes, PHARMACIE DES PINS generated a net profit of 67 k€ in 2025.
Where is the headquarters of PHARMACIE DES PINS ?
The headquarters of PHARMACIE DES PINS is located in BEAUMONT-LES-VALENCE (26760), in the department Drome.
Where to find the tax return of PHARMACIE DES PINS ?
The tax return of PHARMACIE DES PINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES PINS operate?
PHARMACIE DES PINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart